Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this warning letter was issued to BioModeling Solutions, Inc. on January 12, 2018, regarding an unspecified product category classified as "Other." Without access to the full letter text or detailed subject information, the specific nature of the regulatory violations cannot be determined from the available metadata. The issuing FDA office is also not identified in the provided information, limiting clarity on the regulatory scope and product category involved.